Current Opinion in Pulmonary Medicine

Article	Citations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	70
Bronchoscopic treatment of early-stage peripheral lung cancer	41
The persistent problem of persistent air-leaks: approach to management	33
Thoracic computed tomography in the progressive fibrotic phenotype	29
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	27
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	26
The role of PET in the management of sarcoidosis	26
The evolving role of radiological imaging in cystic fibrosis	25
Home monitoring in asthma: towards digital twins	25
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	24
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease	22
Improving care in lung cancer surgery: a review of quality measures and evolving standards	21
Digital outcome measures in pulmonary clinical trials	20
The different facets of sickle cell disease-related pulmonary hypertension	20
The justification for the progressive fibrotic phenotype	18
Direct oral anticoagulant use in special populations	18
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	18
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients	17
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	17
Group 2 pulmonary hypertension: from diagnosis to treatment	17
Bronchoscopic diagnosis of peripheral lung lesions	17
Editorial: A future focus on cystic fibrosis in an era of uncertainty despite opportunity	16
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	16
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	16
Editorial introductions	16

Implementation of digital home monitoring and management of respiratory disease	16
Considerations and clinical management of infections in sarcoidosis	14
Editorial introductions	14
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies	14
Asthma in pregnancy: a review of recent literature	14
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	13
Lung transplant referral considerations for individuals with cystic fibrosis	13
The future of clinical trials in idiopathic pulmonary fibrosis	13
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	13
Casting light on the many facets of sarcoidosis	12
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	12
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	12
The emerging role of inorganic elements as potential antigens in sarcoidosis	11
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	11
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	11
Cystic fibrosis liver disease in the post-modulator era	11
Acute rejection post lung transplant	11
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	11
Tobacco treatment in the setting of lung cancer screening	11
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	11
Progress for all: addressing disparities in sarcoidosis	11
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	10
Imaging in peripheral bronchoscopy	10
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators	10
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	10
What causes cough in pulmonary fibrosis, and how should we treat it?	10
Digital inhalers for asthma management	10
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	9
Novel insights in fibrotic pulmonary sarcoidosis	9
Home monitoring of coronavirus disease 2019 patients in different phases of disease	9
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?	9
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	9
Patterns of progression in non-IPF fibrotic interstitial lung disease	9
Editorial: Are we ready for prime time?	9
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	8
Exhaled breath analysis in interstitial lung disease	8
Altered pharmacology and toxicology during ageing: implications for lung disease	8
Multidisciplinary care in nonmalignant central airway obstruction	8
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease	8
Editorial: ‘What is your occupation?’: historical snippets	8
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective	8
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	8
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	8
Epigenetics and aging: relevance for sleep medicine	8
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	8
Effectiveness and safety of coronavirus disease 2019 vaccines	8
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	8
Infection control in cystic fibrosis: evolving perspectives and challenges	8
Telerehabilitation in pulmonary diseases	8
The association of preexisting severe asthma with COVID-19 outcomes	8

The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease	7
Telehealth and virtual health monitoring in cystic fibrosis	7
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	7
Adenotonsillectomy: the good, the bad and the unknown	7
Right ventricular assessment in pulmonary hypertension	7
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections	7
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	7
The changing landscape of infections in the lung transplant recipient	7
Occupational exposures and sarcoidosis: current understanding and knowledge gaps	7
Ergonomics in bronchoscopy	6
Advancements in airway stents: a comprehensive update	6
Examining the impact of air pollution, climate change, and social determinants of health on asthma and environmental justice	6
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?	6
Prader–Willi syndrome: an update	6
Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?	6
Approach to the hospitalized patient with pulmonary arterial hypertension	6
Editorial introductions	6
Editorial introductions	6
Military deployment-related respiratory problems: an update	6
Shifting gears: the search for group 3 pulmonary hypertension treatment	6
Long-term safety, durability of response, cessation and switching of biologics	6
Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions	6
Editorial introductions	6
Updates in the diagnosis and management of chronic thromboembolic disease	6
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	6
Methamphetamine-associated pulmonary arterial hypertension	5
Artificial intelligence for the optimal management of community-acquired pneumonia	5
Clinical trials in pulmonary sarcoidosis; what is needed, what is happening and what is next?	5
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases	5
Bronchoscopic interventions for chronic bronchitis	5
Editorial introductions	5
Bronchoscopic lung volume reduction in emphysema: a review	5
Lobar or sublobar resection of peripheral stage I non-small cell lung cancer	5
Interrelationships between tuberculosis and chronic obstructive pulmonary disease	5
Rapid eye movement predominant obstructive sleep apnoea: prognostic relevance and clinical approach	5
Editorial introductions	5
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice	5
COVID-19 outcomes in people with cystic fibrosis	5
Recent advances predict a bright future for nebulizers	5
Health inequities in the modulator era	5
Pulmonary alveolar proteinosis – current and future therapeutical strategies	5
Bacteriophages for bronchiectasis: treatment of the future?	5
Editorial introductions	4
Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine	4
Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties	4
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes	4
Drug-resistant tuberculosis: advances in diagnosis and management	4
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis	4
Editorial: Endobronchial valve placement for endoscopic lung volume reduction (ELVR): “the start of a new era”	4
Interstitial lung disease following coronavirus disease 2019	4
Indwelling pleural catheters for benign pleural effusions: a concise review	4
Anesthetic considerations in interventional pulmonology	4
Cyclic alternating patterns and arousals: what is relevant in obstructive sleep apnea? In Memoriam Mario Giovanni Terzano	4
Editorial: The role of ageing in pulmonary disease	4
The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus	4
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment	4
Lung infections due to emerging fungal pathogens	4
Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)	4
Role of biomarkers in lung nodule evaluation	4
What is new in mediastinal staging?	4
Editorial introductions	3
‘Personalized medicine’: phenotyping pediatric obstructive sleep apnea	3
Recent developments in occupational asthma	3
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics	3
The progressive fibrotic phenotype in current clinical practice	3
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates	3
The treatment of sarcoidosis: translating the European respiratory guidelines into clinical practice	3
Whole lung lavage: considerations from the anesthesiology perspective	3
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension	3
Endobronchial treatment of severe asthma and severe emphysema with hyperinflation	3
Risk stratification of pulmonary embolism	3
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide	3
Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019	3
Perioperative management of Obstructive Sleep Apnoea: Present themes and future directions	3
Epidemiology of advanced cystic fibrosis lung disease in the modulator era	3
COVID-19: vaccines, efficacy and effects on variants	3
Editorial introduction	3
Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment	3
Environmental and occupational exposures in interstitial lung disease	3
Editorial introductions	3

COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes	3
Management of complicated parapneumonic effusions	3
Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 2021	3
Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how?	3
Lung transplantation: practical and important directions of care	2
Pregnancy and fertility in people with cystic fibrosis following lung transplantation	2
Pulmonary adverse events following immune checkpoint inhibitors	2
Optimal long-term anticoagulation after acute pulmonary embolism: current state of the art and a look into the near future	2
Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world – opportunities and challenges	2
Progress and challenges in fungal lung disease in cystic fibrosis	2
Treatment strategies for malignant pulmonary nodule: beyond lobectomy. Point-counterpoint	2
Progress in the radiologic diagnosis of idiopathic pulmonary fibrosis	2
Drug-induced sarcoidosis-like reactions	2
Glymphatic MRI techniques in sleep and neurodegenerative diseases	2
Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic	2
SMART - is it practical in the United States?	2
Senescence in pulmonary arterial hypertension: is there a link?	2
The controversy over daylight saving time: evidence for and against	2
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: advances in patient and lesion selection	2
Telehealth and its implementation in respiratory sleep medicine	2
Vitamin D deficiency in chronic obstructive pulmonary disease	2
Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment	2
Keeping global focus on the many challenges of respiratory tract infections	2
Ageing with Interstitial lung disease: preserving health and well being	2
Editorial: The game is changing in sarcoidosis	2
Diversity and disparity in the treatment and care of sarcoidosis	2
Sex differences in sleep and sleep-disordered breathing	2
Bedside to bench and back again-translational research in interventional pulmonology	2
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?	2
Predictors and markers of the cardiovascular impact of obstructive sleep apnoea	2
Leveraging AI technology in sarcoidosis	2
Hit-hard and early versus step-up treatment in severe sarcoidosis	2
Update on the genetic basis of obstructive sleep apnoea – hype or hope?	2
Chronic obstructive pulmonary disease and COVID-19: interrelationships	2